One Year Results from the Thoraflex Hybrid US IDE Trial: Breakthrough

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Terumo Aortic

Committed to Aortic Care. Together with our customers, we strive to create effective management of aortic disease and drive the evolution of our cardiovascular solutions for our patients.

This is the official VuMedi channel of Terumo Aortic. It is only intended for medical professionals and is not a substitute for ...
read more ↘ medical advice nor promotion of any medical procedure or product. Please be advised that not all of our products shown on this channel are registered in, approved for sale in, or available for purchase in, all countries or regions where this channel is accessible.
↖ read less

Surgical
Endovascular
Hybrid
Custom Solutions

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time -0:00

0.5x
0.75x
1x, selected
1.25x
1.5x
1.75x
2x

Chapters

descriptions off, selected

captions settings, opens captions settings dialog
captions off, selected

This is a modal window.

Beginning of dialog window. Escape will cancel and close the window.

TextColorTransparency

BackgroundColorTransparency

WindowColorTransparency

Font Size

Text Edge Style

Font Family

End of dialog window.

10 seconds

Playback speed

This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.

One Year Results from the Thoraflex Hybrid US IDE Trial: Breakthrough

By Terumo Aortic FEATURING S. Chris Malaisrie

134 views

June 14, 2021

Chris Malaisrie presents on the results of the Thoraflex Hybrid US IDE Trial, including; an overview of worldwide published outcomes, technical experiences from the US IDE trial and the related 30-day outcomes.

The content, discussion and opinions expressed in this video are those of the physician and may not be reflective of the approved indications for use of the device, which may also differ by region. Please consult eifu.terumoaortic.com for product indications, contraindications and warnings/precautions.